Immunogenicity, safety and reactogenicity of a Phase II trial of Vi-DT typhoid conjugate vaccine in healthy Filipino infants and toddlers: A preliminary report.

Autor:	Capeding, Maria Rosario1 (AUTHOR), Alberto, Edison1 (AUTHOR), Sil, Arijit2 (AUTHOR), Saluja, Tarun1,2 (AUTHOR) tarun.saluja@ivi.int, Teshome, Samuel2 (AUTHOR), Kim, Deok Ryun2 (AUTHOR), Park, Ju Yeon2 (AUTHOR), Yang, Jae Seung2 (AUTHOR), Chinaworapong, Suchada2 (AUTHOR), Park, Jiwook2 (AUTHOR), Jo, Sue-Kyoung2 (AUTHOR), Chon, Yun2 (AUTHOR), Yang, Seon-Young3 (AUTHOR), Ham, Dong Soo3 (AUTHOR), Ryu, Ji Hwa3 (AUTHOR), Lynch, Julia2 (AUTHOR), Kim, Jerome H.2 (AUTHOR), Kim, Hun3 (AUTHOR), Excler, Jean-Louis2 (AUTHOR), Wartel, T. Anh2 (AUTHOR)
Zdroj:	Vaccine. Jun2020, Vol. 38 Issue 28, p4476-4483. 8p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect